« Previous
Next »
American Journal of Cardiology
Volume 96, Issue 6
, Pages 810-814
, 15 September 2005
Effects of Pomegranate Juice Consumption on Myocardial Perfusion in Patients With Coronary Heart Disease
References
- . Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation (studies in humans and in atherosclerotic apolipoprotein E-deficient mice) . Am J Clin Nutr . 2000;71:1062–1076
- . Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing . J Agric Food Chem . 2000;48:4581–4589
- . Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation . Clin Nutr . 2004;23:423–433
- . Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT (risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction) . J Nucl Med . 2001;42:831–837
-
.
Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases
.
Free Radic Res
. 2000;33:S85–S97
- . Flavonoid antioxidants protect LDL from oxidation and attenuate atherosclerosis . Curr Opin Lipidol . 2001;12:41–48
- Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases (studies in atherosclerotic mice and in humans) . Drugs Exp Clin Res . 2002;28:49–62
-
.
Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis
.
Free Radic Res
. 2002;36:S71–S73
-
.
Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release
.
Circulation
. 2001;103:2792–2798
- . Wine and endothelial function . Drugs Exp Clin Res . 2003;29:235–242
This study was supported by a grant from the Resnick Foundation, Los Angeles, California, to the Preventive Medicine Research Institute, which also provided the pomegranate juice. The foundation did not participate in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the report.
PII: S0002-9149(05)01027-1
doi: 10.1016/j.amjcard.2005.05.026
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 96, Issue 6
, Pages 810-814
, 15 September 2005
